Prevalence of Hepatitis C and B Virus Among Patients Infected with HIV: a Cross-sectional Analysis of a Large HIV Care Programme in Myanmar

Overview

Journal Trop Doct

Specialty Tropical Medicine

Date 2013 Jun 27

PMID 23800421

Citations 20

Authors

Sai Ko Ko Zaw

Sai Thein Than Tun

Aye Thida

Thet Ko Aung

Win Maung

Myint Shwe

Mar Mar Aye

Phillipe Clevenbergh

Affiliations

Soon will be listed here.

Abstract

Co-infection with the hepatitis C virus (HCV) and/or hepatitis B virus (HBV) influences the morbidity and mortality of patients with HIV. A cross sectional analysis was of 11,032 HIV-infected patients enrolled in the Integrated HIV Care Program from May 2005 to April 2012 and Epi-info 3.5 was used to determine the serological prevalence of chronic hepatitis B and hepatitis C. The mean ± standard deviation age of patients was 36 ± 8.4 years (adult cohort) and 7 ± 3 years (paediatric cohort). The sero prevalence of hepatitis B surface antigen, hepatitis C (anti HCV antibodies) and triple infection are 8.7%, 5.3% and 0.35%, respectively. Men who have sex with men are at the highest risk of being co-infected with hepatitis B while intravenous drug users are at the highest risk of being co-infected with hepatitis C. It is important to screen for hepatitis B and C in HIV infected people in order to provide quality care for HIV patients with co-infection.

Citing Articles

Intermediate hepatitis C virus (HCV) endemicity and its genotype distribution in Myanmar: A systematic review and meta-analysis.

Phyo Z, Ko K, Ouoba S, Sugiyama A, Mirzaev U, Akuffo G PLoS One. 2024; 19(9):e0307872.

PMID: 39298388 PMC: 11412534. DOI: 10.1371/journal.pone.0307872.

Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in Myanmar.

Pisa P, Kinge C, Chasela C, Mothibi E, Thaung Y, Thwin H J Clin Virol. 2024; 171:105653.

PMID: 38408420 PMC: 11178258. DOI: 10.1016/j.jcv.2024.105653.

Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.

Ross J, Rupasinghe D, Avihingsanon A, Lee M, Pujari S, Sharp G PLoS One. 2023; 18(6):e0287909.

PMID: 37379314 PMC: 10306215. DOI: 10.1371/journal.pone.0287909.

Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar.

Nyein P, Tillakeratne S, Phyu S, Yee M, Lwin M, Htike K Viruses. 2023; 15(2).

PMID: 36851736 PMC: 9967037. DOI: 10.3390/v15020521.

Epidemiological characteristics and real-world treatment outcomes of hepatitis C among HIV/HCV co-infected patients in Myanmar: A prospective cohort study.

Swe T, Johnson D, Mar H, Thit P, Homan T, Chu C Health Sci Rep. 2023; 6(2):e1119.

PMID: 36819986 PMC: 9938359. DOI: 10.1002/hsr2.1119.